ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 161 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,869,000 | -12.4% | 38,555 | -22.7% | 0.41% | -11.9% |
| Q4 2019 | $2,134,000 | +24.6% | 49,891 | +4.9% | 0.47% | +3.5% |
| Q3 2019 | $1,712,000 | -20.7% | 47,562 | -28.5% | 0.45% | +39.4% |
| Q2 2016 | $2,160,000 | +89.5% | 66,537 | +41.9% | 0.32% | +58.5% |
| Q1 2014 | $1,140,000 | -7.5% | 46,875 | -5.0% | 0.20% | -7.2% |
| Q4 2013 | $1,233,000 | -43.4% | 49,335 | -37.8% | 0.22% | -49.2% |
| Q3 2013 | $2,179,000 | -21.1% | 79,340 | -47.8% | 0.44% | -27.4% |
| Q2 2013 | $2,760,000 | – | 152,055 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |